Blog Genetic Linkage of P8 and K1 By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq December 20, 2020 The K1 Genetic Variant Affects COL6A3, a Gene Encoding a Collagen By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq November 13, 2020 The P8 Genetic Variant Affects PYROXD1, a Gene Required for Oxidative Defense By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 5, 2020 Peer Review Fails to Identify Errors in Inconclusive Study of Genetic Variants of Equine Muscle Genes By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq July 1, 2020 Genetic Basis of Exercise Intolerance in Arabians By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq April 20, 2020 The Px Allele of CACNA2D3 May Affect Splicing of a Component of the Voltage-Gated Calcium Channel By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq February 8, 2020 Mechanism of muscle damage in filaminopathy By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq February 1, 2020 Genetic Linkage of P2 and P4 By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq January 20, 2020 Filamin C (FLNC) By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq January 13, 2020 P3 Allele of FLNC is Associated with Myofibrillar Myopathy in Horses By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq January 13, 2020 Is PSSM2 Genetic? By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq December 13, 2019 Myotilin By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 25, 2019 Arabian MFM By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 13, 2019 Polysaccharide Storage Myopathy type 2 (PSSM2) By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 4, 2019 Polysaccharide Storage Myopathy type 1 (PSSM1) By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq September 29, 2019 Jax By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq September 17, 2019 Negative Nitrogen Balance By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq August 16, 2019